Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
6.97
-0.13 (-1.83%)
At close: Oct 16, 2026, 4:00 PM EDT
6.87
-0.10 (-1.48%)
After-hours: Oct 16, 2026, 7:30 PM EDT
Immunic Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Immunic stock has a consensus rating of "Strong Buy" and an average price target of $43.09. The average 1-year stock price forecast is 518.22% higher than the current stock price, while the lowest is $22 (+215.64%) and the highest is $85 (+1,119.51%).
Price Target: $43.09 (+518.22%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Immunic stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 10 | 11 | 12 | 12 | 12 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 10 | 11 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $25 | Buy | Reiterates | $25 | +258.68% | Oct 8, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $56 | Buy | Maintains | $56 | +703.44% | Sep 11, 2026 |
Unknown Analyst Leerink Partners No rating | Leerink Partners | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 10, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $22 | Buy | Reiterates | $22 | +215.64% | Sep 10, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 10, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.57
from -6.20
EPS Next Year
-2.43
from -3.57
EPS and Forward PE are based on non-GAAP adjusted numbers.